STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Institutional holder Federated Hermes reports 5,116,598 shares (11.26%) in SCYNEXIS

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Federated Hermes, Inc. and related Reporting Persons report beneficial ownership of 5,116,598 shares of Scynexis Inc. common stock, representing 11.26% of the outstanding shares as of the event date 09/30/2025. The filing is an Amendment to Schedule 13G and lists ownership held by Federated Hermes, Inc., Voting Shares Irrevocable Trust, and three individual reporting persons who share voting and dispositive power over the same block. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. Signatures for the filing and trust acknowledgments are dated 10/07/2025, with exhibits noted for subsidiary classification, a joint filing agreement, and a power of attorney.

Positive

  • Material institutional ownership: Federated Hermes holds 5,116,598 shares representing 11.26%, which can provide investor oversight and stewardship
  • Clean intent statement: The filing explicitly states holdings were acquired in the ordinary course and not to change or influence control

Negative

  • None.

Insights

An institutional holder reports an 11.26% stake, a material ownership level for investors.

The filing shows Federated Hermes, Inc. and the Voting Shares Irrevocable Trust collectively hold 5,116,598 shares, equal to 11.26% of the class. Ownership is reported with sole voting and dispositive power by Federated Hermes and shared voting/dispositive power by individual trustees, indicating centralized control over the block.

The statement that shares are held in the ordinary course of business and not for control purposes reduces governance-change signaling, but the >5% position remains material to shareholders. Watch for any follow-up amendments, changes in percentage, or schedule filings that would indicate active engagement or additional accumulation within the next few reporting periods.

A single institutional holder plus an associated trust holding >10% can influence governance outcomes indirectly.

The report lists voting arrangements where Federated Hermes reports sole voting and dispositive power while related individuals report shared powers over the same 5,116,598 shares. This structure is commonly used to centralize stewardship decisions while fulfilling reporting rules.

Because the filing explicitly disclaims intent to change control, immediate governance action is not claimed. Investors should monitor proxy season filings and any investor communications for potential voting recommendations or nominee activity over the next 6–12 months.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Federated Hermes, Inc.
Signature:/s/J. Christopher Donahue
Name/Title:J. Christopher Donahue, as President of Federated Hermes, Inc.
Date:10/07/2025
Voting Shares Irrevocable Trust
Signature:/s/Thomas R. Donahue
Name/Title:Thomas R. Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:10/07/2025
Signature:/s/Ann C. Donahue
Name/Title:Ann C. Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:10/07/2025
Signature:/s/J. Christopher Donahue
Name/Title:J. Christopher Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:10/07/2025
Thomas R. Donahue
Signature:/s/Thomas R. Donahue
Name/Title:Thomas R. Donahue
Date:10/07/2025
Ann C. Donahue
Signature:/s/Ann C. Donahue
Name/Title:Ann C. Donahue
Date:10/07/2025
J. Christopher Donahue
Signature:/s/J. Christopher Donahue
Name/Title:J. Christopher Donahue
Date:10/07/2025

Comments accompanying signature: SEE EXHIBITS 2 AND 3 ATTACHED Exhibit Information EXHIBIT 1 ITEM 3 CLASSIFICATION OF REPORTING PERSON EXHIBIT 2 AGREEMENT FOR JOINT FILING OF SCHEDULE 13G EXHIBIT 3 POWER OF ATTORNEY

FAQ

What stake does Federated Hermes hold in SCYNEXIS (SCYX)?

Federated Hermes, Inc. reports beneficial ownership of 5,116,598 shares, equal to 11.26% of SCYNEXIS common stock.

Does the filing state Federated Hermes intends to change control of SCYNEXIS (SCYX)?

No. The filing certifies the securities were acquired and are held in the ordinary course of business and were not acquired to change or influence control.

Who else is listed as a reporting person on the Schedule 13G/A for SCYNEXIS?

The Voting Shares Irrevocable Trust and individuals Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue are named, each reported with the same aggregate beneficial ownership.

When was the Schedule 13G/A signature dated?

Signatures for the filing and trust acknowledgments are dated 10/07/2025 and the event date requiring the filing is 09/30/2025.

Does the filing include exhibits or supporting agreements?

Yes. Exhibits referenced include an Item 3 classification exhibit, an agreement for joint filing, and a power of attorney.
Scynexis

NASDAQ:SCYX

SCYX Rankings

SCYX Latest News

SCYX Latest SEC Filings

SCYX Stock Data

27.57M
41.06M
2.09%
26.58%
1.18%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
JERSEY CITY